April 30th 2024
A study presented at ESCMID examines the efficacy and safety of the vaccine in older populations.
Researchers Discover Effective Vaccine Program for Dengue-Affected Countries
October 20th 2016Researchers at Sanofi Pasteur, have developed a “transmission model” for Dengue and assessed the population impact of vaccination in the 10 countries participating in the Phase III efficacy studies for CYD-TDV/Dengvaxia.
Read More
High Effectiveness and Increased Vaccination Rates Mark Success of HPV Vaccine
October 12th 2016In the 10 years since the human papilloma virus (HPV) vaccine first became available, a series of new studies have come out showing just how effective the virus really is and how HPV vaccination rates can be improved in adolescents.
Read More
Healthcare Provider Attitudes Toward Seasonal Influenza Vaccine Policies
October 8th 2016To assess factors associated with the likelihood that healthcare providers will accept seasonal influenza vaccine policy changes, Nova Scotia researchers examined the roles that their knowledge and attitude play in the matter.
Read More
Michigan Varicella Outbreak Associated with Riding a School Bus
September 16th 2016A varicella outbreak that had occurred last year in Michigan is thought to be associated with riding on a school bus, which makes small, enclosed spaces, such as a school bus, a risk factor for both transmitting and acquiring airborne diseases.
Watch
Walgreens & HHS Provide Uninsured Americans with $10 Million Worth of Free Flu Shot Vouchers
September 15th 2016Walgreens has partnered up again with the US Department of Health in an effort to improve rates of flu vaccination by providing over $10 million in free flu shot vouchers for Americans who are uninsured.
Read More
Genetically Diverse Viral Antigens Needed to Win the Fight Against Viral Pathogens
August 21st 2016A new model of the within-host evolutionary arms race between viral pathogens and the adaptive immune responses intended to fight them suggests that vaccines based on genetically diverse sets of viral antigens may be more likely to stimulate the production of antibodies capable of neutralizing broad panels of virions.
Read More
New RNA Vaccines May Reduce Disease Outbreak Response Time
August 3rd 2016Engineers at the Massachusetts Institute of Technology have developed a new type of customizable vaccines using messenger RNA that has proven to effectively combat a wide range of lethal pathogens when administered to mice, and might be able to reduce disease outbreak response time in the future.
Read More
Have Researchers Finally Found the Key to a Universal Influenza Vaccine?
July 28th 2016Investigators at the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI) believe they have found the key to developing a universal vaccine for influenza.
Read More